Role of Activated Cdc42-Associated Kinase 1 (ACK1/TNK2)-Inhibitors in Precision Oncology
Activated Cdc42-associated kinase 1 (ACK1) is an intracellular non-receptor tyrosine kinase referred to as TNK2, which is considered as an oncogene and therapeutic target in various cancers including breast cancer, non-small-cell lung cancer (NSCLC), hepatocellular carcinoma (HCC), and many others....
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/80170 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Role of Activated Cdc42-Associated Kinase 1 (ACK1/TNK2)-Inhibitors in Precision Oncology
- The Role of Kinase Inhibitors in Cancer Therapies
- Artificial Intelligence Multiomics in Precision Oncology /
- Protein Kinase Inhibitors - Selectivity or Toxicity?
- Resistance Mechanisms Associated with Treatment with Tyrosine Kinase Inhibitors in Philadelphia Positive Leukemias
- SNF1/AMP-Activated Protein Kinases: Genes, Expression and Biological Role
- Importance of Protein Kinase and Its Inhibitor: A Review